ADMA Biologics Inc. (ADMA)

ADMA trades at $15.61, 2.4% below the near-term max pain of $16 expiring Oct 17, 2025 (18 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($5-$19), reflecting growing call interest at higher strikes. Key magnetic zone at 15 where 3 expirations converge.

Max pain for ADMA shows an upward trend from 5 to 19, suggesting bullish positioning in longer-dated options. The 99% spread signals divergent expectations across timeframes. Levels distributed around 15.61. Strong magnetic level at 15 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.